ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
HORIZON KINETICS MEDICAL ETF
34.96
-0.3314
-0.94%
成交量：
588
成交額：
2.06萬
市值：
1,642.82萬
市盈率：
- -
高：
35.04
開：
34.99
低：
34.96
收：
35.29
52周最高：
37.90
52周最低：
28.87
股本：
46.99萬
流通股本：
46.99萬
量比：
0.27
換手率：
0.13%
股息：
0.41
股息率：
1.17%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
酶的戰爭：一場或將重塑全球創新藥競爭格局的「皮下革命」
蓝鲸财经
·
09/08
中信建投：醫療器械業績持續改善 醫療服務收入平穩增長
智通财经
·
09/08
聯邦制藥(03933.HK)：UBT251注射液完成中國2型糖尿病III期臨床研究首例試驗參與者給藥
智通财经
·
09/07
上半年創新藥冰火兩重天：百濟神州一款藥賣了超160億元，六成藥企還在求生
每日经济新闻
·
09/07
三諾生物：取得醫療器械註冊證及註冊變更文件
智通财经
·
09/07
繼諾華之後，諾和諾德(NVO.US)終止兩項心血管臨床試驗
智通财经
·
09/07
榮昌生物：關於參加科創板2026年半年度創新藥行業集體業績説明會的公告
证券日报网
·
09/07
安圖生物：公司及子公司獲得四項醫療器械註冊證
智通财经
·
09/07
艾迪藥業：關於參加科創板2026年半年度創新藥行業集體業績説明會的公告
证券日报网
·
09/07
諾華降膽固醇藥物遭遇挫折，令人們對新興心臟病藥物的期望蒙上陰影
路透中文
·
09/07
轉型陣痛的昂利康：傳統業務增長失速，豪賭創新藥前景未明
市场资讯
·
09/07
諾華製藥股價下跌3%，因後期試驗顯示其藥物未能降低心臟病發作和中風風險。
智通财经
·
09/07
諾華股價下跌，因一項膽固醇藥物研究失敗加劇了研發管線壓力
路透中文
·
09/07
一周兩度受挫！諾華(NVS.US)心臟病重磅藥III期折戟，股價大跌安進(AMGN.US)「躺槍」
智通财经
·
09/07
諾華製藥股價在瑞士寶盛銀行盤前交易中下跌4.2%，此前其實驗性藥物pelacarsen在試驗中未達到關鍵目標。
智通财经
·
09/07
諾華印度公司擬以1.32億美元收購輝瑞旗下Minipress商標
智通财经
·
09/07
麥科田（2041.HK）登陸港交所，平台型醫療器械龍頭起航
格隆汇
·
09/07
山東省寧陽縣市場監管局開展醫療器械專項現場檢查
中国质量新闻网
·
09/07
我國首款AI輔助創新藥獲批上市，機構扎堆關注12只概念股
智通财经
·
09/07
又一家醫療器械企業登陸港股，麥科田(02041)「含金量」幾何？
智通财经
·
09/07
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/MEDX/news?page=10"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":34.9577,"timestamp":1789502400000,"preClose":35.2891,"halted":0,"volume":588,"delay":0,"changeRate":-0.009391001754082565,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"盤前交易","change":-0.3314,"latestTime":"09-16 06:14:23 EDT","open":34.99,"high":35.04,"low":34.9577,"amount":20606,"amplitude":0.002332,"askPrice":55.58,"askSize":100,"bidPrice":14.06,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":34.9577,"sharesOutstanding":569946,"nav":35.26,"aum":16570295.96,"dividendRate":0.0117,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.04,"preClose":34.9577,"latestTime":"16:10 EDT","volume":6,"amount":209.6308,"timestamp":1789503007392,"change":0.0823,"changeRate":0.002354,"amplitude":0},"volumeRatio":0.2679303977521077},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.2679303977521077,"shares":469946,"dividePrice":0.409,"high":35.04,"amplitude":0.002332,"preClose":35.2891,"low":34.9577,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":34.9577,"eps":0,"divideRate":0.0117,"volume":588,"delay":0,"ttmEps":0,"open":34.99,"prevYearClose":33.2024,"prevWeekClose":34.9572,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":35.4213,"twentyDayClose":35.8903,"sixtyDayClose":33.8763},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665341826","title":"酶的戰爭：一場或將重塑全球創新藥競爭格局的「皮下革命」","url":"https://stock-news.laohu8.com/highlight/detail?id=2665341826","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665341826?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 11:13","pubTimestamp":1788837196,"startTime":"0","endTime":"0","summary":"算上诺华，已有10家全球制药巨头为ALT-B4签下许可协议。有意思的地方在于：这些交易里没有一款新药。2025年9月，默沙东的Keytruda Qlex获FDA批准，成为首个使用ALT-B4的商业化产品。第一张牌，宝济药业的“国产first”。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788753577275365008","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1161","BK1574","IBBQ","LNGR","159992","MEDX","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665434161","title":"中信建投：醫療器械業績持續改善 醫療服務收入平穩增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2665434161","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665434161?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 10:56","pubTimestamp":1788836160,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中信建投发布研报称，医疗器械板块Q2收入延续增长趋势，单季度利润增速四年来首次转正。IVD：26Q2 IVD板块收入在过去两年来首次恢复正增长，利润端大幅增长。从收入端来看，二季度板块收入仍保持正增长，其中眼科医疗服务公司2025Q2低基数相对较低，但板块今年二季度收入增速相较一季度的增速有所降低，表明消费环境压力仍然存在。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","MEDX","IEIH","BK1574","601066","RSPH","09996","MDEV","AGNG","HART","BK0276","BK1100","GDOC","LGHT","PTH","LNGR","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665314820","title":"聯邦制藥(03933.HK)：UBT251注射液完成中國2型糖尿病III期臨床研究首例試驗參與者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2665314820","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665314820?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 20:45","pubTimestamp":1788785154,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311078","title":"上半年創新藥冰火兩重天：百濟神州一款藥賣了超160億元，六成藥企還在求生","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311078","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311078?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 20:39","pubTimestamp":1788784781,"startTime":"0","endTime":"0","summary":"2026年上半年财报季收官，中国创新药产业交出了一份分水岭式的答卷。行业正在告别“烧钱讲故事”的阶段，走向“赚钱才是硬道理”的价值兑现期。这种转变并非行业普遍现象，而是由商业化放量、出海授权爆发、资金来源多元化三重力量共同推动的分化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609073866904351.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609073866904351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["MEDX","BK4588","LU1303224171.USD","LU2328871848.SGD","LU1770034418.SGD","BK1161","LNGR","KURE","BK1500","IBBQ","BK4526","06160","ONC","LU0307460666.USD","LU1719994722.HKD","LU0228659784.USD","BK1574","LU1969619763.USD","BK4139","LU0828237510.HKD","BK4585","LU0588546209.SGD","688235","BK1588","LU1251922891.USD","BK1583","159992","BK0239","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665231964","title":"三諾生物：取得醫療器械註冊證及註冊變更文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2665231964","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665231964?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 19:24","pubTimestamp":1788780275,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GDOC","LGHT","LNGR","RSPH","MEDX","IEIH","HART","MDEV","AGNG","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665831989","title":"繼諾華之後，諾和諾德(NVO.US)終止兩項心血管臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2665831989","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665831989?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 19:10","pubTimestamp":1788779458,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE0002141913.USD","BK4585","BMED","LU0211331839.USD","BK4532","MDTX","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","BK4588","BK4578","IE00B4R5TH58.HKD","MEDX","IBBQ","IE00B2B36J28.USD","LU0320765489.SGD","BGIA","IBBJ","PPH","PSYK","LU0070302665.USD","BK4007","NVS","LU0208291251.USD","IE00BJJMRZ35.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665731933","title":"榮昌生物：關於參加科創板2026年半年度創新藥行業集體業績説明會的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2665731933","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665731933?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:43","pubTimestamp":1788777780,"startTime":"0","endTime":"0","summary":"证券日报网讯9月7日，荣昌生物发布公告称，公司计划于2026年9月16日15：00-17：00参加2026年半年度科创板创新药行业集体业绩说明会，就投资者关心的问题进行交流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-07/doc-iniqyzxs9619866.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-07/doc-iniqyzxs9619866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09995","LU2328871848.SGD","BK1583","LU2148510915.USD","LU1969619763.USD","IBBQ","LNGR","MEDX","BK0239","06978","LU1064130708.USD","LU2488822045.USD","BK1574","BK1161","688331","159992","KSTR","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665315638","title":"安圖生物：公司及子公司獲得四項醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315638","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665315638?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:03","pubTimestamp":1788775426,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","RSPH","AGNG","LGHT","LNGR","PTH","MDEV","HART","GDOC","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319730","title":"艾迪藥業：關於參加科創板2026年半年度創新藥行業集體業績説明會的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319730","media":"证券日报网","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665319730?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:01","pubTimestamp":1788775260,"startTime":"0","endTime":"0","summary":"证券日报网讯9月7日，艾迪药业发布公告称，公司计划于2026年9月16日15：00-17：00参与由上海证券交易所主办的科创板2026年半年度创新药行业集体业绩说明会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-07/doc-iniqyzxw5472550.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-07/doc-iniqyzxw5472550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0262","LNGR","BK1574","IBBQ","159992","BK1161","06978","MEDX","KSTR","688488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665699390","title":"諾華降膽固醇藥物遭遇挫折，令人們對新興心臟病藥物的期望蒙上陰影","url":"https://stock-news.laohu8.com/highlight/detail?id=2665699390","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665699390?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768711,"startTime":"0","endTime":"0","summary":"罕见病药物备受期待市场关注点现将转向第四季度其RNA疗法del-desiran的后期临床试验结果。该药物用于治疗一种罕见肌肉疾病，系通过收购Avidity公司获得。诺华公司另一款抗炎药物雷米布替尼针对一种名为脓疱性汗腺炎的皮肤病所开展的研究数据，预计也将于今年公布。该药物上周在多发性硬化症患者的临床试验中取得了成功。这两家竞争对手的药物均在与佩拉卡森类似的临床试验中进行测试，这些试验依赖于确诊的心脏相关事件，且没有明确的结束日期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL4T44Z0IF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","HRTS","AMGN","CANC","XLV","JDOC","BIB","AGNG","LLYZ","TBXU","LU2746668974.SGD","MHIP","GDOC","MEDX","OZEM","LU1551013425.SGD","PPH","ELIL","LLII","PJP","MEDI","VHT","SLN","LU0456855351.SGD","LLY","LU1988902786.USD","LU2491049909.HKD","IE00BK4W5L77.USD","TMED","IBB","IXJ","LU0096364046.USD","THNR","FTXH","LU2324357040.USD","BK4588","ELIS","IYH","NAMS","RXL","LLYX","CURE","IBBQ","WDNA","BK4581","BBH","PBE","TRUH","IHE","ILDR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665904373","title":"轉型陣痛的昂利康：傳統業務增長失速，豪賭創新藥前景未明","url":"https://stock-news.laohu8.com/highlight/detail?id=2665904373","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665904373?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:08","pubTimestamp":1788768480,"startTime":"0","endTime":"0","summary":"证券之星注意到，2026年上半年，昂利康营收、净利双双下滑逾10%，传统业务中原料药收入持续缩水，特色中间体规模更是“腰斩”，成为主要拖累。传统业务增长失速、创新业务远水难解，昂利康能否在多重压力中突围，仍有待时间检验。昂利康提示风险称，肿瘤创新药产品各阶段的成功率相对于其他创新药低，风险较高，不确定性较大。昂利康如何在传统业务与创新药漫长培育期之间找到平衡，才是市场关注的焦点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2026-09-07/doc-iniqyvry5536300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","LNGR","BK0239","159992","06978","BK1161","IBBQ","MEDX","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665397441","title":"諾華製藥股價下跌3%，因後期試驗顯示其藥物未能降低心臟病發作和中風風險。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665397441","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665397441?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:42","pubTimestamp":1788766955,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","NVS","IE00BFTCPJ56.SGD","LU0211331839.USD","IE00B4R5TH58.HKD","BK4007","IE0002141913.USD","MEDX","IE00B2B36J28.USD","IE0009355771.USD","BK4585","LU0320765489.SGD","BK4532","BK4578","LU0208291251.USD","BK4588","PPH","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665739206","title":"諾華股價下跌，因一項膽固醇藥物研究失敗加劇了研發管線壓力","url":"https://stock-news.laohu8.com/highlight/detail?id=2665739206","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665739206?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:24","pubTimestamp":1788765896,"startTime":"0","endTime":"0","summary":"诺华股价下跌，因一项胆固醇药物研究失败加剧了研发管线压力路透伦敦9月7日-诺华公司的股价周一早盘下跌3.3%，此前该公司的一款降胆固醇药物在一项备受关注的研究中未能达到预期效果，这使得该疗法再次受到质疑，同时也提高了这家瑞士制药商即将公布的基因疗法数据所面临的压力。上周五晚间，诺华表示，在其针对高Lp 患者进行的一项大型晚期研究中，其药物佩拉卡森 未能降低心脏病发作和中风的风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL4T44Z0ES:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","BK4585","IE0002141913.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BK4578","PPH","BK4532","LU0211331839.USD","BK4588","IE00B4R5TH58.HKD","NVS","IE0009355771.USD","LU0070302665.USD","LU0320765489.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","MEDX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392789","title":"一周兩度受挫！諾華(NVS.US)心臟病重磅藥III期折戟，股價大跌安進(AMGN.US)「躺槍」","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392789","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392789?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:15","pubTimestamp":1788765302,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞士制药巨头诺华制药再遭临床试验打击——一周之内，该公司第二项重磅候选药物在后期研究中折戟。此次失利的是其潜在明星心脏病药物pelacarsen。受此消息影响，诺华在美上市股票上周五常规交易结束后一度下跌逾7%。开发类似心脏药物的安进股价上周五盘后也下挫近6%。诺华正寄望于一系列新药来支撑增长，以应对旗下多款重磅产品专利即将到期的压力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1571399168.USD","LU2242646821.SGD","LU2468319806.SGD","LU2089984988.USD","IE00BFTCPJ56.SGD","LU1057294990.SGD","BK4139","PJP","BK4007","LU2112291526.USD","BK4533","MEDX","PBE","LU0058720904.USD","IE00B4R5TH58.HKD","NVS","LU0208291251.USD","BIB","SG9999001440.SGD","LU0122379950.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","BK4566","BK4534","LU0109394709.USD","LU0320765992.SGD","AMGN","LU0868494617.USD","BBH","IBBQ","PPH","LU1023059063.AUD","IE00B2B36J28.USD","BK4532","BK4585","BK4578","IE0009355771.USD","IE0002141913.USD","LU2242652126.USD","IE00BJT1NW94.SGD","BK4581","LU0320765489.SGD","LU0070302665.USD","LU0289739699.SGD","LU0211331839.USD","BK4588","LU0889565916.HKD","IBB","BK4599","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665394493","title":"諾華製藥股價在瑞士寶盛銀行盤前交易中下跌4.2%，此前其實驗性藥物pelacarsen在試驗中未達到關鍵目標。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665394493","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665394493?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:30","pubTimestamp":1788762634,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","MEDX","BK4588","IE0002141913.USD","LU0208291251.USD","BK4585","LU0320765489.SGD","IE00BFTCPJ56.SGD","LU0211331839.USD","BK4532","LU0070302665.USD","IE0009355771.USD","BK4007","PPH","BK4009","BK4578","IE00B2B36J28.USD","BAOS","NVS","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665394397","title":"諾華印度公司擬以1.32億美元收購輝瑞旗下Minipress商標","url":"https://stock-news.laohu8.com/highlight/detail?id=2665394397","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665394397?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:11","pubTimestamp":1788761471,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4578","LU0208291251.USD","IE00B2B36J28.USD","LU0306806265.USD","LU0320765489.SGD","LU0321505439.SGD","IE00B19Z3B42.SGD","LU0225771236.USD","SG9999011175.SGD","IE00BJT1NW94.SGD","NVS","SG9999003800.SGD","BK4532","BK4599","PPH","LU0868494617.USD","IE0002141913.USD","BK4534","IE0002270589.USD","SG9999013999.USD","IE00B4R5TH58.HKD","MEDX","BK4533","IE00BLSP4452.SGD","BK4592","PFE","SG9999002224.SGD","LU0122379950.USD","IE000M9KFDE8.USD","LU0234572021.USD","BK4007","BK4581","SG9999001176.SGD","LU0456855351.SGD","BK4588","LU0070302665.USD","LU1894683348.USD","LU0225284248.USD","LU0211331839.USD","LU0985481810.HKD","IE00BLSP4239.USD","LU0321505868.SGD","LU0289739699.SGD","BK4550","LU0058720904.USD","LU0170899867.USD","LU0306807586.USD","LU1894683264.USD","BK4585","IE00BBT3K403.USD","SG9999001176.USD","LU1023059063.AUD","OZEM","IE00B19Z3581.USD","IE00B3T34201.USD","IE00BJJMRZ35.SGD","BK4568","LU1066051498.USD","IE00BFTCPJ56.SGD","LU1066053197.SGD","SGXZ57979304.SGD","LU1057294990.SGD","LU1883839398.USD","IE0009355771.USD","LU2596442595.SGD","SG9999002232.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665945893","title":"麥科田（2041.HK）登陸港交所，平台型醫療器械龍頭起航","url":"https://stock-news.laohu8.com/highlight/detail?id=2665945893","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665945893?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:10","pubTimestamp":1788761405,"startTime":"0","endTime":"0","summary":"麦科田通过多赛道布局、全球化运营、持续并购整合，构建一个抗周期、可持续的医疗器械平台。","market":"sg","thumbnail":"https://img2.gelonghui.com/52490-957b9937-e172-429c-8c01-0917b7b8c624.jpg?guru_height=2666&guru_width=4000&guru_size=1163899","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/52490-957b9937-e172-429c-8c01-0917b7b8c624.jpg?guru_height=2666&guru_width=4000&guru_size=1163899"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6537932","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LNGR","HEXmain","PTH","LGHT","BK1583","02041","GDOC","MDEV","BK1100","HART","159883","09996","MEDX","BK1574","AGNG","IEIH","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399937","title":"山東省寧陽縣市場監管局開展醫療器械專項現場檢查","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399937","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399937?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:37","pubTimestamp":1788755820,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 9月7日，山东省宁阳县市场监管局执法人员深入辖区零售药店，开展医疗器械专项现场检查。执法人员重点查看血压计等二类医疗器械，仔细核对产品注册资料、进货票据，查验产品有效期、包装标识，排查有无过期失效、来路不明产品等风险隐患。检查过程坚持监管和指导同步开展，现场向药店从业人员讲解医疗器械经营相关规定，指出经营中的不足，督促经营者落实主体责任，规范进货查验和日常自查工作。下一步，该局将持续加大医疗器械监管频次，紧盯零售药店经营风险，切实保障群众用械安全。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-07/doc-iniqykzy9680694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09996","MDEV","AGNG","BK1583","GDOC","HART","IEIH","MEDX","PTH","BK1100","RSPH","159883","BK1574","LNGR","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665628399","title":"我國首款AI輔助創新藥獲批上市，機構扎堆關注12只概念股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665628399","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665628399?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:35","pubTimestamp":1788755705,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ARTY","VTHR","AIPO","IBBQ","CHAT","IPOS","QTOC","MEDX","LNGR","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399350","title":"又一家醫療器械企業登陸港股，麥科田(02041)「含金量」幾何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399350","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399350?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:07","pubTimestamp":1788754034,"startTime":"0","endTime":"0","summary":"随着多家医疗器械企业中报密集披露，医疗器械板块整体修复态势明确，业绩端已出现向上拐点。9月7日，麦科田正式于港交所挂牌上市，这意味着港股医疗器械板块再添一家平台型龙头。据多家权威机构测算，2026年全球医疗器械市场规模预计在6000亿至8000亿美元之间，并有望于2035年突破万亿美元大关。整体来看，麦科田此次登陆港股，业绩方面盈利拐点已经确认，商业化路径成熟，平台型的全面产品组合和全","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492650.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MDEV","BK4588","AGNG","KCAI","BK1574","PTH","GDOC","09996","VXUS","MEDX","HART","LGHT","02041","159883","BK1100","BK4585","BK1583","RSPH","LNGR","IEIH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":10,"totalSize":258,"code":"91000000","status":"200"}]}}